Experiments for taxon Erigeron breviscapus (ASTERACEAE)

Experiments (93 results)

Filters
Worktypes (20)
30
22
22
18
14
13
11
11
9
7
4
3
3
2
1
1
1
1
1
1
No match
Pharmacology (20)
12
3
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
52
No match
Compounds (66)
7
5
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
31
No match
Organisms (34)
18
14
5
5
5
4
4
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
93 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
157366
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE A
269964
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE II
790861
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
267638
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
APIGENIN
265420
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
FLAVONE,4'-5-6-TRIHYDROXY: 7-O-BETA-D-GALACTOPYRANOSIDURONIC ACID
267627
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CHLOROGENIC ACID A,ISO: METHYL ESTER
284245
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
PYRAN-4-ONE-3-YL),1-O-(: 6-O-CAFFEOYL-ALPHA-D-GLUCOSIDEXANTHONE,1-HYDROXY-2-3-5-TRIMETHOXY:
790854
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
267634
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
FRIEDELINOL,EPI:
282418
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
CAFFEOYL-1-O-METHYL-QUINIC ACID,3-5-DI-O: METHYL ESTER
790855
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
157369
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
BETULABUSIDE A
1300771
HPLC SEPARATION DATA FOR
Erigeron breviscapus (ASTERACEAE)
SCUTELLARIN
790850
VOUCHER SPECIMEN REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
790859
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
280715
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
COSMOSIINKAEMPFEROLAPIGENIN-7-O-BETA-D-GLUCURONIDE
624234
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CAFFEIC ACID ETHYL ESTERSCOPOLETIN,ISO:PYROMECONIC ACIDSCOPOLETIN
974717
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
ANTI-STROKE ACTIVITY
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
692723
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Erigeron breviscapus (ASTERACEAE)
269963
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE I
883797
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
APIGENIN-7-O-GLUCURONIDE
790865
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Erigeron breviscapus (ASTERACEAE)
1273037
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
SCUTELLAREIN-7-O-GLUCURONIDE
279045
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
BENZENE-CARBONIC ACID,3-5-DIMETHOXY: 4-O-BETA-D-GLUCOSIDEFLAVONE,4-5-DIHYDROXY: 7-O-BETA-D-PYRANOGLUCURONATE: BUTYL ESTER
157367
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE B
776590
PHARMACOLOGY OF EXTRACT - IN VIVO
PULMONARY ANTIHYPERTENSION ACTIVITY
Erigeron breviscapus (ASTERACEAE)
790851
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
282419
PHARMACOLOGY OF COMPOUND - IN VITRO
RADICAL SCAVENGING EFFECT
Erigeron breviscapus (ASTERACEAE)
CAFFEOYL-1-O-METHYL-QUINIC ACID,3-5-DI-O: METHYL ESTERCAFFEOYL-QUINIC ACID,5-O: BUTYL ESTER
794080
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
ERIGEROSIDE
775379
PROPAGATION STUDIES
Erigeron breviscapus (ASTERACEAE)
1300772
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIOXIDANT ACTIVITY
Erigeron breviscapus (ASTERACEAE)
SCUTELLARIN
790858
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
883798
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANS
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Erigeron breviscapus (ASTERACEAE)
APIGENIN-7-O-GLUCURONIDE
267630
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
PYROMECONIC ACID
267637
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
ERIODICTYOL
232847
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
CYCLOHEXANE-CARBOXYLIC ACID,1(R)-3(R)-DIHYDROXY-4(S)-5(R)-DICAFFEOYL-OXY: METHYL ESTERCYCLOHEXANE-CARBOXYLIC ACID,1-4-DIHYDROXY-3(R)-5(R)-DICAFFEOYL-OXY:
763447
PHARMACOLOGY OF COMPOUND - IN VITRO
TOXIC EFFECT(GENERAL)
Erigeron breviscapus (ASTERACEAE)
PYRONE,4: 3-O-BETA-D-GLUCOSIDE
790862
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
692722
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Erigeron breviscapus (ASTERACEAE)
282421
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
CAFFEOYL-QUINIC ACID,5-O: BUTYL ESTER
734802
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Erigeron breviscapus (ASTERACEAE)
157368
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE C
267626
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CHLOROGENIC ACID A,ISO:
280714
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
FLAVONE,4'-5-6-TRIHYDROXY 7-O-ETHYL-GLUCURONIDE:
750408
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
BENZOIC ACID,4-HYDROXY:SCUTELLARINQUERCETINPROTOCATECHUIC ACIDKAEMPFEROLAPIGENIN
296386
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE BSCOPOLINBLUMENOL C GLUCOSIDEERIGESIDE AERIGESIDE IIERIGESIDE IICARISIDE B-2SYRINGARESINOL-O-BETA-D-GLUCOSIDE,(+):SCUTELLAREIN-7-O-BETA-D-GLUCURONIDE METHYL ESTER
692724
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITHROMBOTIC EFFECT
Erigeron breviscapus (ASTERACEAE)
790852
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
729536
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLC
Erigeron breviscapus (ASTERACEAE)
SCUTELLARIN
488467
PHARMACOLOGY OF COMPOUND - IN VITRO
THROMBOXANE B-2 SYNTHESIS INHIBITION
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
788863
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CHLOROGENIC ACID METHYL ESTERCRYPTOCHLOROGENIC ACID METHYL ESTER
790857
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
267631
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
STIGMASTEROL
282420
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIOXIDANT ACTIVITY
Erigeron breviscapus (ASTERACEAE)
CAFFEOYL-1-O-METHYL-QUINIC ACID,3-5-DI-O: METHYL ESTERCAFFEOYL-QUINIC ACID,5-O: BUTYL ESTER
488468
PHARMACOLOGY OF COMPOUND - IN VITRO
PROSTAGLANDIN F-1-ALPHA-6-KETO SYNTHESIS INHIBITION
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
265421
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
SCUTELLARINBAICALEIN-7-O-BETA-D-GLUCOSIDEBAICALEIN,4'-HYDROXY: 7-O-BETA-D-GLUCOPYRANOSIDURONIC ACID METHYL ESTER
883801
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
SCUTELLAREINCOSMOSIINPLANTAGININAPIGENIN
267625
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGOSTER A
734801
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Erigeron breviscapus (ASTERACEAE)
488470
PHARMACOLOGY OF COMPOUND - IN VITRO
LEUKOTRIENE B4 RELEASE ENHANCEMENT
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
790863
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Erigeron breviscapus (ASTERACEAE)
296385
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE D
883799
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
SCUTELLAREIN-7-O-GLUCURONIDE
672331
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIISCHEMIC EFFECT
Erigeron breviscapus (ASTERACEAE)
267636
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CAFFEIC ACID
267629
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CHLOROGENIC ACID B,ISO: METHYL ESTER
790860
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
267628
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
CHLOROGENIC ACID B,ISO:
692721
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Erigeron breviscapus (ASTERACEAE)
790867
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
284246
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL ADHESION INHIBITION
Erigeron breviscapus (ASTERACEAE)
XANTHONE,1-HYDROXY-2-3-5-TRIMETHOXY:
488469
PHARMACOLOGY OF COMPOUND - IN VITRO
THROMBOXANE B-2 SYNTHESIS INHIBITION
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
714236
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
SCUTELLAREINNARINGENINFLAVONE,3-4'-5-6-7-PENTAHYDROXY:FLAVONE,3-4'-5-6-TETRAHYDROXY-7-METHOXY:APIGENIN
267635
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
STIGMASTEROL-3-O-BETA-D-GLUCOSIDE
790856
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
300990
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE E
763446
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
PYRONE,4: 3-O-BETA-D-GLUCOSIDE
706597
ISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
ACRYLIC ACID,BETA-(PARA-METHOXY-PHENYL):BENZOIC ACID,4-HYDROXY:PHENYLACRYLIC ACID,BETA:PROTOCATECHUIC ACIDCAFFEIC ACID METHYL ESTER
883800
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANS
CARDIOVASCULAR EFFECTS(UNSPECIFIED)
Erigeron breviscapus (ASTERACEAE)
SCUTELLAREIN-7-O-GLUCURONIDE
488466
PRESENT IN (REVIEW)
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
157365
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
ERIGEROSIDE
267633
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
FRIEDELIN
790853
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
974716
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
BREVISCAPINE
1300770
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Erigeron breviscapus (ASTERACEAE)
267632
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Erigeron breviscapus (ASTERACEAE)
SUCCINIC ANHYDRIDE
1286082
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTEIN KINASE C INHIBITION
Erigeron breviscapus (ASTERACEAE)
257274
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
ERIGESIDE I
1286083
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERLEUKIN-2 FORMATION INHIBITION
Erigeron breviscapus (ASTERACEAE)
638364
PHARMACOLOGY OF EXTRACT - IN VIVO
DIABETIC ANGIOPATHY IMPROVEMENT
Erigeron breviscapus (ASTERACEAE)
790864
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIYEAST ACTIVITY
Erigeron breviscapus (ASTERACEAE)
790866
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIFUNGAL ACTIVITY
Erigeron breviscapus (ASTERACEAE)
280920
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Erigeron breviscapus (ASTERACEAE)
CYCLOHEXANE-CARBOXYLIC ACID,1(R)-3(R)-DIHYDROXY-4(S)-5(R)-DICAFFEOYL-OXY: METHYL ESTERCYCLOHEXANE-CARBOXYLIC ACID,1-4-DIHYDROXY-3(R)-5(R)-DICAFFEOYL-OXY: METHYL ESTER